Case Study
Digital Therapeutics Landscape and patient adoption
Building the case for change for Digital Therapeutics in a large pharmaceutical company
- Cardiovascular • Diabetes • Kidney Disease • Oncology • Respiratory
- Countries: Global Scope
- Timeline: 10 to 11 months
Key Deliverables
0
+
digital therapeutics companies reviewed
0
people surveyed
0
capabilities mapped across DTx lifecycle
Client
A pharma company with a large portfolio and siloed initiatives
Key Question
How to build the case for a digital therapeutics (DTx) strategy at enterprise level?
Our approach
We’ve proposed an approach with 4 key dimensions:
- The industry landscape: a summary strategy document covering definition of DTx, early success stories, regulatory and reimbursement pathways, typology of DTx, approaches to value generation
- The innovation review with 50+ DTx companies in relevant disease areas
- The internal view: stakeholder interviews to understand drivers of uncertainty, leading to a capability mapping across DTx lifecycle
- The patient view to understand patient readiness to adopt DTx, with patients focus groups and a quantitative, multi-country study, to understand attitudes towards DTx (awareness, interest, readiness to pay) and help lift internal objections and misconceptions
Results
- Projects materials were used for wide stakeholder engagement across many functions to align on definitions, strategic intent, roles and capabilities, enabling the cross-functional taskforce to secure senior sponsorship in multiple functional areas for the DTx agenda.
- Materials were adapted into a 2-h training curriculum on the internal training platform for wider enterprise circulation.
- Patient research was presented internally at global, regional and country level, and leveraged for external thought leadership interventions in leading DTx conference.
Client Feedback
Related Case Studies
Digital Therapeutics exploration
Scoping the Digital Therapeutics opportunity in pain management & scanning for potential partners
Patient-centered design for a digital companion
Identifying what patients need from a companion app to help manage their chronic condition
Digital strategy: the patient of the future
Anticipating patients’ expectations for digital health in 5 years to future-proof digital strategy
